ARTICLE | Company News
Kinaxo, Bristol-Myers deal
October 18, 2010 7:00 AM UTC
Kinaxo will use its Cellular Target Profiling and KinAffinity proteomics technologies to indentify the cellular protein targets of Bristol-Myers's compounds in discovery. Financial terms were not disc...